Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy
Cancer Cell · 2024-06 · 42 (6) · 1051-1066.e7
DOI: 10.1016/j.ccell.2024.05.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-06. Verfasst von Shannon N Geels und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Immunology, University of California, Irvine, Irvine, CA, USA; Department of Physiology and Biophysics, University of California, Irvin…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, T-Lymphocytes, Regulatory, Programmed Cell Death 1 Receptor, Melanoma. Die Arbeit wurde bisher 125-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
PD-1 blockade unleashes potent antitumor activity in CD8+ T cells but can also promote immunosuppressive T regulatory (Treg) cells, which may worsen the response to immunotherapy. Tumor-Treg inhibition is a promising strategy to improve the efficacy of checkpoint blockade immunotherapy; however, our understanding of the mechanisms supporting tumor-Tregs during PD-1 immunotherapy is incomplete. Here, we show that PD-1 blockade increases tumor-Tregs in mouse models of melanoma and metastatic melanoma patients. Mechanistically, Treg accumulation is not caused by Treg-intrinsic inhibition of PD-1 signaling but depends on an indirect effect of activated CD8+ T cells. CD8+ T cells produce IL-2 and colocalize with Tregs in mouse and human melanomas. IL-2 upregulates the anti-apoptotic protein ICOS on tumor-Tregs, promoting their accumulation. Inhibition of ICOS signaling before PD-1 immunotherapy improves control over immunogenic melanoma. Thus, interrupting the intratumor CD8+ T cell:Treg crosstalk represents a strategy to enhance the therapeutic efficacy of PD-1 immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Immunology, University of California, Irvine, Irvine, CA, USA; Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, USA.
- Institute for Immunology, University of California, Irvine, Irvine, CA, USA; Center for Complex Biological Systems, University of California, Irvine, Irvine, CA, USA; NSF-Simons Center for Multiscale Cell Fate Research,…
- Department of Translational Molecular Medicine, Saint John's Cancer Institute, Santa Monica, CA, USA.
- Center for Complex Biological Systems, University of California, Irvine, Irvine, CA, USA; NSF-Simons Center for Multiscale Cell Fate Research, University of California, Irvine, Irvine, CA, USA.
- Institute for Immunology, University of California, Irvine, Irvine, CA, USA; Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA.
- Department of Pathology, University of Alabama, Birmingham, Birmingham, AL, USA.
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIAMS NIH HHS
- NINDS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Science Foundation
- Melanoma Research Alliance
- Heising-Simons Foundation
Zitieren
APA
Geels, S. N., Moshensky, A., Sousa, R. S., Murat, C., Bustos, M. A., Walker, B. L., Singh, R., Harbour, S. N., Gutierrez, G., Hwang, M., Mempel, T. R., Weaver, C. T., Nie, Q., Hoon, D. S. B., Ganesan, A. K., Othy, S., & Marangoni, F. (2024). Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy. Cancer Cell, 42(6), 1051-1066.e7. https://doi.org/10.1016/j.ccell.2024.05.013
Vancouver
Geels SN, Moshensky A, Sousa RS, Murat C, Bustos MA, Walker BL, et al. Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy. Cancer Cell. 2024;42(6):1051-1066.e7. doi:10.1016/j.ccell.2024.05.013
BibTeX
@article{Geels2024,
author = {Geels, Shannon N and Moshensky, Alexander and Sousa, Rachel S and Murat, Claire and Bustos, Matias A and Walker, Benjamin L and Singh, Rima and Harbour, Stacey N and Gutierrez, Giselle and Hwang, Michael and Mempel, Thorsten R and Weaver, Casey T and Nie, Qing and Hoon, Dave S B and Ganesan, Anand K and Othy, Shivashankar and Marangoni, Francesco},
title = {Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {6},
pages = {1051--1066.e7},
doi = {10.1016/j.ccell.2024.05.013}
}
EUVIMED